UBE2D4 Human

Ubiquitin Conjugating Enzyme E2D4 Human Recombinant

Recombinantly produced in E.coli, UBE2D4 Human Recombinant is a single, non-glycosylated polypeptide chain. It comprises 167 amino acids (residues 1-147) and exhibits a molecular mass of 18.8 kDa. The protein features a 20 amino acid His-tag fused at the N-terminus and is purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT17802
Source
E.coli.
Appearance
A colorless solution that has undergone sterile filtration.

UBE2L3 Human

Ubiquitin-Conjugating Enzyme E2L 3 Human Recombinant

Recombinant human Ubiquitin-Conjugating Enzyme E2L3, expressed in E. coli, is a single, non-glycosylated polypeptide chain. It comprises 154 amino acids, resulting in a molecular weight of 17.9 kDa.
Shipped with Ice Packs
Cat. No.
BT18726
Source
Escherichia Coli.
Appearance
Clear, colorless solution, sterile-filtered.

UBE2L3 Human His

Ubiquitin-Conjugating Enzyme E2L 3 Human Recombinant, His Tag

Recombinant Human Ubiquitin-Conjugating Enzyme E2L 3 (UBE2L3), expressed in E. coli, is an 18.9 kDa protein comprising 162 amino acids. This protein includes a 6xHis tag and is purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT18811
Source
Escherichia Coli.
Appearance
White, lyophilized powder, sterile filtered.

UBE2L6 Human

Ubiquitin Conjugating Enzyme E2L 6 Human Recombinant

Recombinantly produced in E.Coli, UBE2L6 Human Recombinant is a single, non-glycosylated polypeptide chain. It consists of 188 amino acids (with the active protein encompassing residues 1-152) and has a molecular weight of 21.7 kDa. The protein is engineered with a 36 amino acid His Tag at the N-terminus to facilitate purification, which is achieved through standard chromatography techniques.
Shipped with Ice Packs
Cat. No.
BT18899
Source
Escherichia Coli.
Appearance
A clear, colorless solution that has been sterilized by filtration.

UBE2M Human

Ubiquitin Conjugating Enzyme E2M Human Recombinant

This product consists of the recombinant human UBE2M protein, expressed in E. coli and purified to a high degree. The protein encompasses amino acids 1 to 183 of the UBE2M sequence, with an additional 24-amino acid His-tag at the N-terminus. The molecular weight of the tagged protein is 23.5 kDa.
Shipped with Ice Packs
Cat. No.
BT19116
Source
Escherichia Coli.
Appearance
The product is a clear, colorless solution that has been sterilized by filtration.

UBE2N Human

Ubiquitin Conjugating Enzyme E2N Human Recombinant

UBE2N, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 172 amino acids (1-152a.a.) with a molecular weight of 19.3 kDa. It is fused to a 20 amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT19224
Source
Escherichia Coli.
Appearance
A sterile, colorless solution.

UBE2Q2 Human

Ubiquitin Conjugating Enzyme E2Q2 Human Recombinant

Recombinant human UBE2Q2, expressed in E. coli, is a non-glycosylated polypeptide chain consisting of 398 amino acids (1-375a.a.) with a molecular weight of 45.2kDa. It includes a 23 amino acid His-tag at the N-terminus and is purified using proprietary chromatographic methods.
Shipped with Ice Packs
Cat. No.
BT19311
Source
Escherichia Coli.
Appearance
Clear, sterile-filtered solution.

UBE2R2 Human

Ubiquitin Conjugating Enzyme E2R 2 Human Recombinant

Recombinant human UBE2R2, produced in E. coli, is a single, non-glycosylated polypeptide chain. It comprises 261 amino acids (1-238 a.a) and has a molecular mass of 29.6kDa. (Note: On SDS-PAGE, the molecular size may appear higher). The protein is fused to a 23 amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT19386
Source
Escherichia Coli.
Appearance
Clear solution, sterile-filtered.

UBE2S Human

Ubiquitin Conjugating Enzyme E2S Human Recombinant

Recombinant human UBE2S, with a 36 amino acid His tag at the N-terminus, is produced in E. coli. It is a single, non-glycosylated polypeptide chain comprising 258 amino acids (1-222 a.a.) and has a molecular weight of 27.9kDa. UBE2S is purified using proprietary chromatographic methods.
Shipped with Ice Packs
Cat. No.
BT19468
Source
Escherichia Coli.
Appearance
A clear, colorless solution that has been sterilized by filtration.

UBE2T Human

Ubiquitin-Conjugating Enzyme E2T Human Recombinant

Recombinant human UBE2T, expressed in E. coli, is a non-glycosylated polypeptide chain consisting of 205 amino acids (1-197 a.a.). It has a molecular weight of 23.6 kDa. This protein includes an 8 amino acid His Tag at the C-terminus and is purified through proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT19553
Source
Escherichia Coli.
Appearance
A clear, colorless solution that has been sterilized through filtration.
Definition and Classification

Ubiquitin Conjugating Enzymes (E2 enzymes) are a family of enzymes that play a crucial role in the ubiquitination process, which is essential for protein degradation, signal transduction, and various cellular processes. These enzymes are classified based on their sequence homology and structural features into several families, including UBC, UEV, and others.

Biological Properties

Key Biological Properties: E2 enzymes are characterized by their ability to transfer ubiquitin from an E1 activating enzyme to a substrate protein, often in conjunction with an E3 ligase. They possess a conserved catalytic core domain known as the UBC domain.

Expression Patterns: The expression of E2 enzymes varies widely among different tissues and cell types. Some E2 enzymes are ubiquitously expressed, while others show tissue-specific expression patterns.

Tissue Distribution: E2 enzymes are found in various tissues, including the brain, liver, heart, and muscles. Their distribution is often linked to the specific cellular functions they regulate.

Biological Functions

Primary Biological Functions: The primary function of E2 enzymes is to facilitate the transfer of ubiquitin to target proteins, marking them for degradation by the proteasome. This process is vital for maintaining protein homeostasis and regulating various cellular pathways.

Role in Immune Responses: E2 enzymes are involved in the regulation of immune responses by modulating the stability and activity of key signaling proteins. They play a role in the activation and termination of immune signaling pathways.

Pathogen Recognition: E2 enzymes contribute to the recognition and elimination of pathogens by regulating the ubiquitination of proteins involved in pathogen sensing and response.

Modes of Action

Mechanisms with Other Molecules and Cells: E2 enzymes interact with E1 activating enzymes to receive ubiquitin and then transfer it to substrate proteins in collaboration with E3 ligases. This interaction is highly specific and regulated.

Binding Partners: E2 enzymes have specific binding partners, including E1 enzymes, E3 ligases, and substrate proteins. These interactions determine the specificity and efficiency of the ubiquitination process.

Downstream Signaling Cascades: The ubiquitination of target proteins by E2 enzymes can activate or inhibit downstream signaling cascades, affecting various cellular processes such as cell cycle progression, DNA repair, and apoptosis.

Regulatory Mechanisms

Expression and Activity Control: The expression and activity of E2 enzymes are tightly regulated at multiple levels, including transcriptional and post-transcriptional mechanisms.

Transcriptional Regulation: The transcription of E2 enzyme genes is controlled by various transcription factors and signaling pathways, ensuring their expression is responsive to cellular needs.

Post-Translational Modifications: E2 enzymes themselves can be modified post-translationally, such as by phosphorylation or ubiquitination, which can alter their activity, stability, and interactions.

Applications

Biomedical Research: E2 enzymes are studied extensively in biomedical research for their roles in disease mechanisms, particularly in cancer, neurodegenerative diseases, and immune disorders.

Diagnostic Tools: The expression levels and activity of specific E2 enzymes can serve as biomarkers for certain diseases, aiding in diagnosis and prognosis.

Therapeutic Strategies: Targeting E2 enzymes with small molecules or inhibitors is being explored as a therapeutic strategy for diseases where dysregulated ubiquitination plays a key role.

Role in the Life Cycle

Development: E2 enzymes are essential for proper development, as they regulate the degradation of proteins involved in cell differentiation and growth.

Aging: The activity of E2 enzymes can influence the aging process by affecting the turnover of damaged or misfolded proteins, which accumulate with age.

Disease: Dysregulation of E2 enzyme activity is implicated in various diseases, including cancer, neurodegenerative disorders, and immune diseases. Understanding their role in these conditions can lead to new therapeutic approaches.

© Copyright 2024 Thebiotek. All Rights Reserved.